Zugck, C., Kell, R., Kirschke, A. E., Schellberg, D., Loßnitzer, D., Haass, M., & Haunstetter, A. (2001). Do we have to reassess classical risk predictors in patients with congestive heart failure since initiation of β-blocker treatment? European heart journal, 22, . https://doi.org/10.1093/eurheartj/22.Abstract_Supplement.1
Chicago-Zitierstil (17. Ausg.)Zugck, Christian, Robert Kell, Andreas Erich Kirschke, Dieter Schellberg, Dirk Loßnitzer, Markus Haass, und Armin Haunstetter. "Do We Have to Reassess Classical Risk Predictors in Patients with Congestive Heart Failure Since Initiation of β-blocker Treatment?" European Heart Journal 22 (2001). https://doi.org/10.1093/eurheartj/22.Abstract_Supplement.1.
MLA-Zitierstil (9. Ausg.)Zugck, Christian, et al. "Do We Have to Reassess Classical Risk Predictors in Patients with Congestive Heart Failure Since Initiation of β-blocker Treatment?" European Heart Journal, vol. 22, 2001, https://doi.org/10.1093/eurheartj/22.Abstract_Supplement.1.